Home › Compare › GWBK vs JNJ

GWBK vs JNJ: Dividend Comparison 2026

GWBK yields 3076.92% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GWBK wins by $578804600665.47M in total portfolio value
10 years
GWBK
GWBK
● Live price
3076.92%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$578804600665.50M
Annual income
$544,023,840,488,516,100.00
Full GWBK calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GWBK vs JNJ

📍 GWBK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGWBKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GWBK + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GWBK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GWBK
Annual income on $10K today (after 15% tax)
$261,538.46/yr
After 10yr DRIP, annual income (after tax)
$462,420,264,415,238,660.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GWBK beats the other by $462,420,264,415,234,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GWBK + JNJ for your $10,000?

GWBK: 50%JNJ: 50%
100% JNJ50/50100% GWBK
Portfolio after 10yr
$289402300332.76M
Annual income
$272,011,920,244,260,380.00/yr
Blended yield
93.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GWBK
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GWBK buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGWBKJNJ
Forward yield3076.92% ✓2.13%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$578804600665.50M ✓$30.3K
Annual income after 10y$544,023,840,488,516,100.00 ✓$4,689.40
Total dividends collected$576403114825.48M ✓$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GWBK vs JNJ ($10,000, DRIP)

YearGWBK PortfolioGWBK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$318,392$307,692.31$10,592$272.30+$307.8K → GWBK
2$9,496,461$9,155,781.67$11,289$357.73+$9.49M → GWBK
3$265,378,974$255,217,760.17$12,123$472.89+$265.37M → GWBK
4$6,949,441,440$6,665,485,937.77$13,141$629.86+$6949.43M → GWBK
5$170,564,997,752$163,129,095,411.51$14,408$846.81+$170564.98M → GWBK
6$3,924,365,658,393$3,741,861,110,798.54$16,021$1,151.60+$3924365.64M → GWBK
7$84,659,703,250,880$80,460,631,996,399.20$18,122$1,588.22+$84659703.23M → GWBK
8$1,712,795,370,094,185$1,622,209,487,615,743.00$20,930$2,228.20+$1712795370.07M → GWBK
9$32,505,383,342,974,930$30,672,692,296,974,148.00$24,792$3,191.91+$32505383342.95M → GWBK
10$578,804,600,665,499,400$544,023,840,488,516,100.00$30,274$4,689.40+$578804600665.47M → GWBK

GWBK vs JNJ: Complete Analysis 2026

GWBK — Stock

Gateway Bank, F.S.B. provides personal and commercial banking products and services in California. The company provides Personal Banking products and services, including checking accounts, savings accounts, certificate of deposit, and individual retirement accounts; and online banking services. It also offers business banking products and services, including checking and savings accounts, money market accounts, and certificate of deposit; and merchant banking services. Gateway Bank, F.S.B. was formerly known as Gateway Bank FSB and changed the name to Gateway Bank, F.S.B. in October, 2010. Gateway Bank, F.S.B. was founded in 1990 and is based in Oakland, California. Gateway Bank, F.S.B. operates as a subsidiary of SK&LLWANG, LLC.

Full GWBK Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GWBK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GWBK vs SCHDGWBK vs JEPIGWBK vs OGWBK vs KOGWBK vs MAINGWBK vs ABBVGWBK vs MRKGWBK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.